EE279 Cost-Effectiveness of T-DM1 vs. Trastuzumab for Adjuvant Treatment in HER2 Early Breast Cancer (eBC) With Residual Disease in Colombia
Abstract
Authors
Melissa Diaz Diego Ballén MILTON LOMBANA Daniel Samaca Claudia Hernández-Castillo Juliana Saavedra